Kim Kardashian’s SKKY Partners Takes Minority Stake in 111Skin

111SKIN is taking a significant minority investment from SKKY Partners, the consumer-focused private equity firm co-founded by Jay Sammons and Kim Kardashian.

With SKKY’s support, 111SKIN aims to strengthen its direct-to-consumer business while expanding its customer base in key markets, including North America and Asia. The two cofounders, Eva and Dr. Yannis Alexandrides, will retain majority ownership and continue to lead the company, along with CEO Vanessa Goddevrind.

Goldman Sachs International acted as sole placement agent on the transaction, and Raymond James served as financial advisor to SKKY Partners.

Financial terms of the transaction were not disclosed.

“We are excited to join forces with visionary partners that will help us write the future success story of our brand,” said Dr. Yannis and Eva Alexandrides, cofounders of 111SKIN. “The SKKY Partners team has tremendous experience working with distinctive, growth-oriented brands. They are passionate champions of our core values and share our drive for excellence,” added CEO Vanessa Goddevrind.

Founded in 2012 by plastic and reconstructive surgeon Dr. Yannis Alexandrides, 111SKIN says it champions clinically inspired formulations, effective active ingredients and “breakthrough technologies.” Leveraging Dr. Yannis’s decades of experience successfully treating patients in London’s 111 Harley Street Clinic, 111SKIN’s advancements include its proprietary NAC Y2 ingredient complex.